Terrence C Kearney's Net Worth

$33.3 Million

Estimate Recalculated Nov 1, 2024 04:29AM EST

Who is Terrence C Kearney?

Terrence C Kearney has an estimated net worth of $33.3 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, THERAVANCE INC, AveXis, Inc., ACCELERON PHARMA INC, and HOSPIRA INC.

SEC CIK

Terrence C Kearney's CIK is 0001289098

Past Insider Trading and Trends

2004 was Terrence C Kearney's most active year for acquiring shares with 33 total transactions. Terrence C Kearney's most active month to acquire stocks was the month of April. 2010 was Terrence C Kearney's most active year for disposing of shares, totalling 29 transactions. Terrence C Kearney's most active month to dispose stocks was the month of October. 2010 saw Terrence C Kearney paying a total of $15,476,315.80 for 664,758.25 shares, this is the most they've acquired in one year. In 2010 Terrence C Kearney cashed out on 881,271 shares for a total of $26,189,608.61, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 1
Form 4
—
0
$238.77
-$2,224,600.00
6.54K
Aug 10
Form 4
—
0
—
—
0
May 1
Form 4
+12.48%
725
—
—
6.54K
May 1
Form 4
—
0
—
—
0
May 1
Form 4
—
0
—
—
0
Jun 1
Form 4
-46.25%
-5.00K
$139.59
-$6,733,232.52
5.81K
Scheduled
Oct 31 - Nov 1
Form 4
+28.24%
2.38K
—
—
10.81K
Jun 1
Form 4
+27.17%
1.8K
—
—
8.43K
Jun 1
Form 4
+49.27%
2.19K
—
—
6.63K
Jun 1
Form 4
+196.07%
2.94K
$0.01
$29.41
4.44K
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
∞
1.5K
$56.99
$85,485.00
1.5K
May 19
Form 4
—
0
$92.97
-$4,924,441.35
0
Scheduled
Apr 27
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
May 17
Form 3
—
0
—
—
0
No matching records found

THERAVANCE INC (INVA) Snapshot price: $18.7201

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+60.30%
13.95K
—
—
37.08K
Apr 24
Form 4
∞
23.13K
—
—
23.13K
Oct 30
Form 3
—
0
—
—
0
No matching records found

AveXis, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.11K
—
—
0
May 15
Form 4
∞
1.11K
—
—
1.11K
Mar 13
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
Feb 10
Form 3
—
0
—
—
0
No matching records found

ACCELERON PHARMA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.75K
—
—
0
Nov 19
Form 4
+31.64%
1.62K
—
—
6.75K
Jan 29
Form 4
—
0
$73.99
-$3,402,605.68
5.13K
Scheduled
Oct 12
Form 4
+36.72%
1.38K
—
—
5.13K
Jan 22
Form 4
+50.00%
1.25K
—
—
3.75K
Jan 25
Form 4
+100.00%
1.25K
—
—
2.5K
Mar 1
Form 4
∞
1.25K
—
—
1.25K
Mar 2
Form 4
—
0
—
—
0
Mar 3
Form 4/A
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Jul 14
Form 3
—
0
—
—
0
No matching records found

HOSPIRA INC No price found

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-69.76%
-110.00K
$44.74
-$7,989,419.42
47.68K
Scheduled
Dec 15 - Dec 16
Form 4
+4.42%
6.67K
$54.04
-$336,800.17
157.68K
Scheduled
Oct 21
Form 4
+42.13%
44.76K
$41.45
-$1,682,921.43
151K
Scheduled
Sep 27
Form 4
+1.17%
1.23K
$50.57
-$44,914.54
106.24K
Scheduled
Sep 21
Form 4
+0.82%
853
$49.69
-$30,818.27
105.02K
Scheduled
Sep 16
Form 4
+15.20%
13.75K
$48.93
-$497,679.49
104.16K
Scheduled
Apr 20
Form 4
+3.26%
2.86K
$48.04
-$105,833.80
90.42K
Scheduled
Mar 30
Form 4
+0.73%
632
$45.52
-$24,905.69
87.56K
Scheduled
Feb 19
Form 4
—
0
—
—
0
Feb 11
Form 4
—
0
$44.90
-$5,018.20
86.92K
Nov 5
Form 4
+12.77%
9.84K
$41.55
-$279,868.26
86.92K
Scheduled
Oct 19
Form 4
+1.85%
1.4K
$40.32
-$41,000.92
77.08K
Scheduled
Sep 29
Form 4
—
0
—
—
0
Mar 5
Form 4
—
0
—
—
0
Mar 6
Form 4
+1.26%
941
$39.51
-$26,891.92
75.68K
Dec 10
Form 4
+0.52%
386
$38.61
-$10,760.48
74.74K
Nov 29
Form 4
+6.19%
4.34K
$37.67
-$122,946.09
74.35K
Nov 28
Form 4
—
0
—
—
0
May 15
Form 4
+7.67%
4.99K
$35.27
-$110,990.18
70.02K
Mar 2
Form 4
+3.86%
2.42K
$33.05
-$57,954.85
65.03K
Jan 29
Form 4
+2.40%
1.47K
$32.02
-$44,054.00
62.61K
Jan 23
Form 4
+1.30%
782
$28.56
-$17,391.44
61.15K
Dec 18
Form 4
+56.87%
21.88K
$33.24
-$562,765.44
60.36K
Jun 16
Form 4
—
0
—
—
0
May 17
Form 4
+45.42%
12.02K
$35.20
-$138,747.41
38.48K
Dec 15
Form 4
+10.22%
2.45K
$38.07
-$65,126.25
26.46K
Sep 9
Form 4
+28.68%
5.35K
$32.68
-$136,832.71
24.01K
Jun 14
Form 4
—
0
—
—
0
May 9
Form 4
+1.29%
238
$29.56
-$7,686.76
18.66K
Mar 10
Form 4
+233.01%
12.89K
$23.86
-$324.81
18.42K
Dec 13
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 3
Form 3
—
0
—
—
0
No matching records found